Fol. Biol. 2022, 68, 33-39
https://doi.org/10.14712/fb2022068010033
RTKN2 Enhances Radioresistance in Gastric Cancer through Regulating the Wnt/β-Catenin Signalling Pathway
References
1. , M., Rafiei, H., Mohammadinejad, R., Farkhondeh, T., Samarghandian, S. (2020) Wnt-regulating microRNAs role in gastric cancer malignancy. Life Sci. 250, 117547.
<https://doi.org/10.1016/j.lfs.2020.117547>
2. , H.-C., Tsai, C.-Y., Wang, C.-S., Yang, H.-Y., Lo, C.-H., Wang, W.-J., Lee, K.-F., Lai, L.-Y., Hong, J.-H., Chang, Y.-F., Tsai, M.-M., Yeh, C.-T., Wu, C. H., Hsieh, C.-C., Wang, L.-H., Chen, W.-J., Lin, K.-H. (2020) DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/β-catenin signaling and cancer stem cell traits. Oncogene 39, 5933-5949.
<https://doi.org/10.1038/s41388-020-01390-0>
3. , M. A. (2015) Role of the Wnt/β-catenin pathway in gastric cancer: an in-depth literature review. World J. Exp. Med. 5, 84-102.
<https://doi.org/10.5493/wjem.v5.i2.84>
4. , F., Gregorio-King, C., Gough, T., Talbot, C. D., Walder, K., Kirkland, M. (2004) Identification and characterization of a lymphocytic Rho-GTPase effector: Rhotekin-2. Biochem. Bioph. Res. Commun. 324, 1360-1369.
<https://doi.org/10.1016/j.bbrc.2004.09.205>
5. , F. M., Loving, A., Baker, A. J., McLeod, J., Walder, K., Kirkland, M. A. (2009) RTKN2 induces NF-KappaB dependent resistance to intrinsic apoptosis in HEK cells and regulates BCL-2 genes in human CD4+ lymphocytes. J. Cell Death 2, 9-23.
<https://doi.org/10.4137/JCD.S2891>
6. , Q., Li, D., Luo, X., Yuan, Y., Li, T., Liu, H., Wang, X. (2021) The regulatory network and potential role of LINC00973-miRNA-mRNA ceRNA in the progression of non-small-cell lung cancer. Front. Immunol. 12, 684807.
<https://doi.org/10.3389/fimmu.2021.684807>
7. , Ł., Imiela, J. (2016) Diet and Helicobacter pylori infection. Prz. Gastroenterol. 11, 150-154.
8. , G., Liang, M., Liu, H., Huang, J., Li, P., Wang, C., Zhang, Y., Lin, Y., Jiang, X. (2020) CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway. Cell Death Dis. 11, 1065-1065.
<https://doi.org/10.1038/s41419-020-03276-1>
9. , L., Huang, Y., Zhang, Y., Peng, A., Qin, J., Lu, S., Huang, Y. (2020) RTKN2 is associated with unfavorable prognosis and promotes progression in non-small-cell lung cancer. Onco Targets Ther. 13, 10729-10738.
<https://doi.org/10.2147/OTT.S260436>
10. , W., Wu, Y.-F., Xu, R.-H., Lu, H., Hu, C., Qian, H. (2014) miR-1246 releases RTKN2-dependent resistance to UVB-induced apoptosis in HaCaT cells. Mol. Cell. Biochem. 394, 299-306.
<https://doi.org/10.1007/s11010-014-2108-1>
11. , Y. X., Zeng, J. M., Zhou, J. J., Yang, G. H., Ding, K., Zhang, X. J. (2016) Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells. Mol. Med. Rep. 13, 4872-4878.
<https://doi.org/10.3892/mmr.2016.5127>
12. , Z., Li, D., Cheng, W., Wu, J., Wang, K., Hu, Y. (2018) MicroRNA-181 functions as an antioncogene and mediates NF-κB pathway by targeting RTKN2 in ovarian cancers. Reprod. Sci. 26, 193371911880586.
13. , C.-A., Wang, M.-J., Chi, C.-W., Wu, C.-W., Chen, J.-Y. (2004) Rho/Rhotekin-mediated NF-κB activation confers resistance to apoptosis. Oncogene 23, 8731-8742.
<https://doi.org/10.1038/sj.onc.1208106>
14. , L., Matei, L., Dragu, D., Neagu, A. I., Mambet, C., Nedeianu, S., Bleotu, C., Diaconu, C. C., Chivu-Economescu, M. (2019) Recent advances in gastric cancer early diagnosis. World J. Gastroenterol. 25, 2029-2044.
<https://doi.org/10.3748/wjg.v25.i17.2029>
15. , X., Li, R., Shi, D., Pan, X., Ma, C., Zhang, G., Mu, C., Chen, W. (2017) Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells. Oncol. Lett. 14, 8028-8034.
16. , C., López-Urrutia, E., García-Castillo, V., Trujano-Camacho, S., Lopez-Camarillo, C., Campos-Parra, A. (2020) Interplay between autophagy and Wnt/β-catenin signaling in cancer: therapeutic potential through drug repositioning. Front. Oncol. 10, 1037.
<https://doi.org/10.3389/fonc.2020.01037>
17. , R., Skierucha, M., Mielko, J., Offerhaus, G. J. A., Maciejewski, R., Polkowski, W. P. (2018) Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag. Res. 10, 239-248.
<https://doi.org/10.2147/CMAR.S149619>
18. , G., Shang, Z., Liu, W. (2021) SPP1 regulates radiotherapy sensitivity of gastric adenocarcinoma via the Wnt/beta-catenin pathway. J. Oncol. 2021, 1642852.
19. , M.-Y., Zhang, H., Tao, J., Ni, Z.-H., Wu, Q.-X., Tang, Q.-F. (2019) Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway. Cancer Manag. Res. 11, 1069-1080.
<https://doi.org/10.2147/CMAR.S185345>
20. , X., Zhang, L., Wang, W., Wang, Y., Chen, Y., Xie, R., Li, X., Wang, Y. (2018) Rhotekin 2 silencing inhibits proliferation and induces apoptosis in human osteosarcoma cells. Biosci. Rep. 38, BSR20181384.
<https://doi.org/10.1042/BSR20181384>
21. , D., Li, L., Yan, W. (2016) Knockdown of TC-1 enhances radiosensitivity of non-small cell lung cancer via the Wnt/β-catenin pathway. Biol. Open 5, 492-498.
<https://doi.org/10.1242/bio.017608>
22. , T.-Y., Hsiao, Y.-W., Peng, W.-H., Wang, M.-J., Chen, J.-Y. (2012) Abstract 4435: Overexpression of Rhotekin confers gastric cancer cells resistance to interferon-α-mediated growth inhibition. Cancer Res. 72, 4435.
<https://doi.org/10.1158/1538-7445.AM2012-4435>
23. , Y., Wang, X. (2020) Targeting the Wnt/β-catenin signaling pathway in cancer. J. Hematol. Oncol. 13, 165.
<https://doi.org/10.1186/s13045-020-00990-3>
24. , Y., Yi, J., Tao, L., Huang, G., Chu, X., Song, H., Chen, L. (2018) Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma. Cell Death Dis. 9, 433-433.
<https://doi.org/10.1038/s41419-018-0466-4>
